Search

Your search keyword '"Papi, Laura"' showing total 379 results

Search Constraints

Start Over You searched for: Author "Papi, Laura" Remove constraint Author: "Papi, Laura"
379 results on '"Papi, Laura"'

Search Results

1. Ovarian cancer pathology characteristics as predictors of variant pathogenicity in BRCA1 and BRCA2

3. Heterozygosity for loss-of-function variants in LZTR1 is associated with isolated multiple café-au-lait macules

4. A novel CDKN2A in-frame deletion associated with pancreatic cancer-melanoma syndrome

5. ERN GENTURIS clinical practice guidelines for the diagnosis, treatment, management and surveillance of people with schwannomatosis

6. A Clinical Workflow for Cost-Saving High-Rate Diagnosis of Genetic Kidney Diseases

7. Polygenic risk modeling for prediction of epithelial ovarian cancer risk

9. When to test fetuses for RASopathies? Proposition from a systematic analysis of 352 multicenter cases and a postnatal cohort

10. Polygenic risk scores and breast and epithelial ovarian cancer risks for carriers of BRCA1 and BRCA2 pathogenic variants

11. Epigenomic, genomic, and transcriptomic landscape of schwannomatosis

12. Correction: Polygenic risk modeling for prediction of epithelial ovarian cancer risk

13. An original phylogenetic approach identified mitochondrial haplogroup T1a1 as inversely associated with breast cancer risk in BRCA2 mutation carriers

14. Expanding the mutational spectrum of LZTR1 in schwannomatosis

15. Identification of six new susceptibility loci for invasive epithelial ovarian cancer.

16. Candidate Genetic Modifiers for Breast and Ovarian Cancer Risk in BRCA1 and BRCA2 Mutation Carriers

17. Associations of common breast cancer susceptibility alleles with risk of breast cancer subtypes in BRCA1 and BRCA2 mutation carriers.

18. Refined histopathological predictors of BRCA1 and BRCA2 mutation status: a large-scale analysis of breast cancer characteristics from the BCAC, CIMBA, and ENIGMA consortia.

19. Refined histopathological predictors of BRCA1 and BRCA2mutation status: a large-scale analysis of breast cancer characteristics from the BCAC, CIMBA, and ENIGMA consortia

20. DNA glycosylases involved in base excision repair may be associated with cancer risk in BRCA1 and BRCA2 mutation carriers.

21. Common breast cancer susceptibility alleles are associated with tumor subtypes in BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1/2.

22. Meta-analysis identifies 29 additional ulcerative colitis risk loci, increasing the number of confirmed associations to 47

24. Supplementary Tables S1-S3 from LZTR1 Mutation Mediates Oncogenesis through Stabilization of EGFR and AXL

25. Supplementary Figure S1. from LZTR1 Mutation Mediates Oncogenesis through Stabilization of EGFR and AXL

26. Data from LZTR1 Mutation Mediates Oncogenesis through Stabilization of EGFR and AXL

27. Central, Eastern, and Southeastern European Countries' Convergence: A Look at the Past and Considerations for the Future

29. Supplementary Table 2 from Candidate Genetic Modifiers for Breast and Ovarian Cancer Risk in BRCA1 and BRCA2 Mutation Carriers

30. Supplementary Table 3 from Candidate Genetic Modifiers for Breast and Ovarian Cancer Risk in BRCA1 and BRCA2 Mutation Carriers

31. Ovarian cancer pathology characteristics as predictors of variant pathogenicity in BRCA1 and BRCA2

32. Correction to: Epigenomic, genomic, and transcriptomic landscape of schwannomatosis

33. Essays on optimal government policy

34. LZTR1 mutation mediates oncogenesis through stabilization of EGFR and AXL

35. A mosaic pattern of INI1/SMARCB1 protein expression distinguishes Schwannomatosis and NF2-associated peripheral schwannomas from solitary peripheral schwannomas and NF2-associated vestibular schwannomas

36. Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer

37. Association of breast cancer risk in BRCA1 and BRCA2 mutation carriers with genetic variants showing differential allelic expression: identification of a modifier of breast cancer risk at locus 11q22.3

38. Updated diagnostic criteria and nomenclature for neurofibromatosis type 2 and schwannomatosis: An international consensus recommendation

39. Turcot Syndrome

41. Assessment of the InSiGHT Interpretation Criteria for the Clinical Classification of 24 MLH1 and MSH2 Gene Variants

42. Revised diagnostic criteria for neurofibromatosis type 1 and Legius syndrome: an international consensus recommendation

43. FANCM c.5791C>T nonsense mutation (rs144567652) induces exon skipping, affects DNA repair activity and is a familial breast cancer risk factor

44. Germline mutations in MSH2 and ATM gene in patients with GIST (gastrointestinal stromal tumor) and second epitelial tumors.

49. Characterization of the Cancer Spectrum in Men With Germline BRCA1 and BRCA2 Pathogenic Variants: Results From the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA)

50. Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses

Catalog

Books, media, physical & digital resources